Cargando…

Inflammatory bowel disease: clinical aspects and treatments

Inflammatory bowel disease (IBD) is defined as a chronic intestinal inflammation that results from host-microbial interactions in a genetically susceptible individual. IBDs are a group of autoimmune diseases that are characterized by inflammation of both the small and large intestine, in which eleme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fakhoury, Marc, Negrulj, Rebecca, Mooranian, Armin, Al-Salami, Hani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106026/ https://www.ncbi.nlm.nih.gov/pubmed/25075198 http://dx.doi.org/10.2147/JIR.S65979

Ejemplares similares

An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
por: Mooranian, Armin, et al.
Publicado: (2014)

Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study
por: Mooranian, Armin, et al.
Publicado: (2014)

Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
por: Lazarević, Slavica, et al.
Publicado: (2022)

Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
por: Mooranian, Armin, et al.
Publicado: (2014)

Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
por: Mooranian, Armin, et al.
Publicado: (2014)

Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases
por: Moon, Jin Soo
Publicado: (2019)

Clinical aspects and treatments for pediatric inflammatory bowel diseases
por: Moon, Jin Soo
Publicado: (2019)

Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
por: Mikov, Momir, et al.
Publicado: (2023)

Nutritional Aspects in Inflammatory Bowel Diseases
por: Balestrieri, Paola, et al.
Publicado: (2020)

Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease
por: Panufnik, Paulina, et al.
Publicado: (2022)

Nutritional aspect of pediatric inflammatory bowel disease: its clinical importance
por: Kim, Seung, et al.
Publicado: (2015)

Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease
por: Dragasevic, Sanja, et al.
Publicado: (2022)

Clinical and Sociodemographic Aspects of Inflammatory Bowel Disease Patients
por: Delmondes, Leda Maria, et al.
Publicado: (2015)

Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions
por: Đanić, Maja, et al.
Publicado: (2023)

Artificial Cell Encapsulation for Biomaterials and Tissue Bio-Nanoengineering: History, Achievements, Limitations, and Future Work for Potential Clinical Applications and Transplantation
por: Mooranian, Armin, et al.
Publicado: (2021)

A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds
por: Mooranian, Armin, et al.
Publicado: (2020)

Bio Micro-Nano Technologies of Antioxidants Optimised Their Pharmacological and Cellular Effects, ex vivo, in Pancreatic β-Cells
por: Mooranian, Armin, et al.
Publicado: (2020)

Advancements in Assessments of Bio-Tissue Engineering and Viable Cell Delivery Matrices Using Bile Acid-Based Pharmacological Biotechnologies
por: Mooranian, Armin, et al.
Publicado: (2021)

A Review on Recent Advancement on Age-Related Hearing Loss: The Applications of Nanotechnology, Drug Pharmacology, and Biotechnology
por: Chester, Jacqueline, et al.
Publicado: (2021)

Pediatric Bowel Management Options and Organizational Aspects
por: Bokova, Elizaveta, et al.
Publicado: (2023)

Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies
por: Wagle, Susbin Raj, et al.
Publicado: (2020)

Pharmacological effects of novel microvesicles of basil, on blood glucose and the lipid profile: a preclinical study
por: Teofilovic, Branislava, et al.
Publicado: (2021)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

Pharmacological and Biological Study of Microencapsulated Probucol-Secondary Bile Acid in a Diseased Mouse Model
por: Wagle, Susbin Raj, et al.
Publicado: (2021)

Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects
por: Zundler, Sebastian, et al.
Publicado: (2017)

The Implications of Oxidative Stress and Antioxidant Therapies in Inflammatory Bowel Disease: Clinical Aspects and Animal Models
por: Balmus, Ioana Miruna, et al.
Publicado: (2016)

The Role of Enteral Nutrition in Patients with Inflammatory Bowel Disease: Current Aspects
por: Triantafillidis, John K., et al.
Publicado: (2015)

Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease
por: Chew, Deborah, et al.
Publicado: (2018)

An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques
por: Mooranian, Armin, et al.
Publicado: (2019)

Probucol Pharmacological and Bio-Nanotechnological Effects on Surgically Transplanted Graft Due to Powerful Anti-Inflammatory, Anti-Fibrotic and Potential Bile Acid Modulatory Actions
por: Mooranian, Armin, et al.
Publicado: (2021)

Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations
por: Wagle, Susbin Raj, et al.
Publicado: (2020)

The Effect of Deoxycholic Acid on Chitosan-Enabled Matrices for Tissue Scaffolding and Injectable Nanogels
por: Kovacevic, Bozica, et al.
Publicado: (2022)

Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview
por: M’Koma, Amosy Ephreim
Publicado: (2022)

Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease
por: Vaidy, Katherine, et al.
Publicado: (2020)

Novel treatments for inflammatory bowel disease
por: Lee, Hyo Sun, et al.
Publicado: (2018)

Emerging treatments for inflammatory bowel disease
por: Hazel, Karl, et al.
Publicado: (2020)

Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
por: Elhag, Duaa Ahmed, et al.
Publicado: (2022)

Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid
por: Majimbi, Maimuna, et al.
Publicado: (2021)

Single-Cellular Biological Effects of Cholesterol-Catabolic Bile Acid-Based Nano/Micro Capsules as Anti-Inflammatory Cell Protective Systems
por: Mooranian, Armin, et al.
Publicado: (2022)

Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions
por: Jones, Melissa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qnb3au5lkqa8n470vhkghd1on2